• Home
  • About
  • Contact
  • Steve Walker
  • Subscriptions
    • Sample MondayMorning Newsletter January 11, 2016
Monday Morning
Skip to content
  • Home
  • About
  • Contact
  • Steve Walker
  • Subscriptions
    • Sample MondayMorning Newsletter January 11, 2016

Tag Archives: Gemcabene

Stock markets closed Friday prior to collapse of Trumpcare; health sector’s biggest winners & losers as of March 24, 2017

Steve Walker    March 27, 2017 June 14, 2017    No Comments on Stock markets closed Friday prior to collapse of Trumpcare; health sector’s biggest winners & losers as of March 24, 2017

Republican bickering has led to the biggest rout yet for President Trump’s early administration. As I expected, the GOP plan to gut the Affordable Care Act collapsed Friday (March 24,… Read more »

Corporate, Investment, Pharmaceuticals    Affordable Care Act, American College of Cardiology, Cerulean Pharma Inc., Christopher Guiffre, Daré Bioscience, European Society for Medical Oncology, Gemcabene, Gemphire Therapeutics Inc., HTG EdgeSeq ALKPlus Assay EU, HTG Molecular Diagnostics Inc., lexion Therapeutics Inc., Obamacare, President Trump, Sanofi SA, Synvisc, TV-45070, XEN801, Xenon Phar­ma­ceu­ti­cals Inc., Zilretta

Search The Site

Follow @MonMorningNews

Twitter

Tweets by MonMorningNews
Follow me on Blogarama

Facebook

Search The Site

More MondayMorning

  • Recent Posts
  • Most Commented
  • Most Viewed
  • Healthcare stocks roar back after slump, while biotech IPOs continue stampede into pipeline.
  • Smartphones are revolutionizing medicine as new apps proliferate. Then there’s the Facebook lesson for and against trusting that your data...
  • US citizen denied life-saving bone-marrow transplant from Iranian brother due to Trump travel ban. My very brief take.
  • Report says hardly any physicians read the medical journals for their particular field. Has era of “evidence-free medicine” finally arrived?
  • Tiny Scottish biotech TauRx lobs bomb into Alzheimer’s fracas with Phase 3 success.
  • CAR-T Therapy: Personalized medicine with the promise of a cure; payers will decide who gets it
  • Akebia shares soar on rich partnership with Otsuka; risky but rational gamble?
  • Although more expensive, study says teaching hospitals save more lives. My personal take.
  • Tiny Scottish biotech TauRx lobs bomb into Alzheimer’s fracas with Phase 3 success.
  • Breakthrough study linking menopause to increased risk of Alzheimer’s explains why far more women than men get the disease; what...
  • Alarming study concludes most new, pricey cancer drugs don’t work; why are we just hearing about this?
  • Rx Hall of Shame Update: Former Insys employee pleads guilty in US opioid drug probe; case against ex CEO Michael...
Copyright 2018
Ribosome by GalussoThemes.com
Powered by WordPress